WASHINGTON (Gray DC) -- President Donald Trump unveiled the broad brushstrokes of his plans to cut into the cost of prescription drugs Friday afternoon.
While the finer points remain unclear, Sen. Bill Cassidy (R-LA) praised the president's plan. He said he's pleased by the president's call for price transparency, making sure rebates reach the pockets of patients, and the potential to negotiate a lower price for Medicare in its dealings with pharmaceutical companies.
Rep. Buddy Carter (R-GA) echoed many of Cassidy's sentiments. He said he expects patients could see lower drug costs in a matter of months. Carter added that a bill he sponsored would prevent insurers from barring physicians from informing patients that their bill could be cheaper if they pay for their medications out-of-pocket.
Both Sen. Bernie Sanders (I-VT) and Sen. Sherrod Brown (D-OH) said they're disappointed the President is not calling for more substantial negotiation of Medicare drug prices. They would also like to see the U.S. import cheaper, FDA-approved drugs from Canada.
Click on the links above to see our full interviews with the lawmakers.